Garvan Institute of Medical Research
OrganisationROR
People
Lead investigator
Lead investigator
Lead investigator
Lead investigator
Sources: openalex.org
Trials
Phase 3, Active, not recruiting, 242 people, 13 Aug 2020
Personalised Medicine in Pre-diabetes and Early Type 2 Diabetes
Completed, 138 people, 15 Jun 2018
Collaborator, Phase 4, Completed, 40 people, 28 Sept 2005
Sources: clinicaltrials.gov
Grants and prizes
2023 Targeted Translation Research Accelerator– Cardiovascular Disease and Diabetes Mechanisms, Repurposed Semaglutide to Bridge the T1d Cardiovascular Risk Gap, MRFCDDM000003, A$916.3k, 2024–2026, 26 Jun 2024
Department of Health, Australian Government
2017_Next_Generation_Clinical_Researchers_PF_commencing_2018, Improving outcomes in osteoporosis and bone health, GA190944, A$361.7k, 2018–2022, 1 Jan 2018
2017 Next Generation Clinical Researchers, Improving outcomes in osteoporosis and bone health, MRF1137462, A$343.7k, 2018–2022, 1 Jan 2018
National Health and Medical Research Council
Project Grants - Standard Project Grant, Premature mortality post fracture:A NSW linked data study, 1108886, A$391k, 2016–2018, 1 Jan 2016
National Health and Medical Research Council
Postgraduate Scholarships - Public Health Postgraduate Scholarship, Osteoporotic Fracture-Mortality Association and the Effect of Anti-osteoporosis Treatment: A Multinational Study, 1114676, A$84.8k, 2016–2018, 1 Jan 2016
Sources: openalex.org